USE OF IL-1 BETA BINDING ANTIBODIES

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Thuren, Tom,Zalewski, Andrew,Shetzline, Michael

申请号：

AU2016202177

公开号：

AU2016202177A1

申请日:

2016.04.07

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

#$%^&*AU2016202177A120160428.pdf#####H: RBR jtenvoven NRPo1blDCC RBR 995499 oI cx-7/04/2016 Abstract The present invention relates to an IL-13 binding antibody or a functional fragment thereof for use in preventing or reducing risk of experiencing a recurrent cardiovascular (CV) 5 event or a cerebrovascular event in a patient that has suffered of a qualifying CV event.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/